EyePoint Pharmaceuticals (EYPT) shares surge as Baird says there are 'multiple catalysts ahead'
Tweet Send to a Friend
EyePoint Pharmaceuticals (NASDAQ: EYPT) was initiated with an Outperform rating and $33 per share price target at Baird on Friday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
